Every SEC Form 3/4/5 on record for this filer (CIK 1372455) — 4 issuers, 61 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | Director | 2025-10-02 → 2026-06-09 | 9 | $274,840 |
| ACGL | ARCH CAPITAL GROUP LTD. | Director | 2016-05-09 → 2026-06-04 | 27 | $339,635 |
| BIIB | BIOGEN INC. | Director · lapsed | 2016-06-09 → 2023-01-27 | 12 | −$684,970 |
| BIVV | Bioverativ Inc. | Director · lapsed | 2017-01-19 → 2018-03-08 | 8 | $166,913 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| DYN | 2026-06-08 | Buy | 2,000 | $16.94 | $33,880 | 24,500 |
| ACGL | 2026-06-03 | Sell | 3,000 | $19.66 | $58,980 | — |
| DYN | 2026-06-03 | Buy | 2,500 | $17.48 | $43,700 | 22,500 |
| DYN | 2026-05-26 | Buy | 2,000 | $18.21 | $36,420 | 20,000 |
| DYN | 2026-05-20 | Buy | 2,500 | $17.12 | $42,800 | 18,000 |
| ACGL | 2026-05-11 | Sell | 2,000 | $17.14 | $34,280 | — |
| DYN | 2026-03-30 | Buy | 2,000 | $17.08 | $34,160 | 15,500 |
| ACGL | 2026-03-11 | Sell | 3,000 | $17.12 | $51,360 | 2,000 |
| DYN | 2026-03-11 | Buy | 2,000 | $19.35 | $38,700 | 13,500 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.
